Vitiligo clinical trials at UC Irvine
4 in progress, 2 open to eligible people
Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)
open to eligible people ages 18 years and up
This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.
Irvine, California and other locations
Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
open to all eligible people
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
Irvine, California and other locations
AMG 714 for Vitiligo
Sorry, in progress, not accepting new patients
This study is designed to evaluate the efficacy of AMG 714 for the treatment of adult participants with vitiligo.
Irvine, California and other locations
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
Sorry, in progress, not accepting new patients
To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.
Irvine, California and other locations
Our lead scientists for Vitiligo research studies include Natasha Mesinkovska, MD.
Last updated: